Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 596

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood

Open access
Zetterberg, Henrik, Smith, Douglas H., Blennow, Kaj·2013·Nature Reviews Neurology
DOI 10.1038/nrneurol.2013.9
Open this paper in CoChat — free account

Abstract

Mild traumatic brain injury (TBI), which is defined as a head trauma resulting in a brief loss of consciousness and/or alteration of mental state, is usually benign, but occasionally causes persistent and sometimes progressive symptoms. Whether a threshold for the amount of brain injury and/or individual vulnerability might contribute to the development of these long-term consequences is unknown. Furthermore, reliable diagnostic methods that can establish whether a blow to the head has affected the brain (and in what way) are lacking. In this Review, we discuss potential biomarkers of injury to different structures and cell types in the CNS that can be detected in body fluids. We present arguments in support of the need for further development and validation of such biomarkers, and for their use in assessing patients with head trauma in whom the brain might have been affected. Specifically, we focus on the need for such biomarkers in the management of sports-related concussion, the most common cause of mild TBI in young individuals, to prevent long-term neurological sequelae due to concussive or subconcussive blows to the head.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrneurol.2013.9

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 113

  1. Roozenbeek, B., Maas, A. I. & Menon, D. K. Opinion: Changing patterns in the epidemiology of traumatic brain injury. Nat. Rev. Neurol. http://dx.doi/org/nrneurol.2013.22 · DOI · Paper page
  2. Blumbergs, P. C. et al. Staining of amyloid precursor protein to study axonal damage in mild head injury. Lancet 344, 1055–1056 (1994). · DOI · Paper page
  3. Baugh, C. M. et al. Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma. Brain Imaging Behav. 6, 244–254 (2012). · DOI · Paper page
  4. Gavett, B. E., Stern, R. A. & McKee, A. C. Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma. Clin. Sports Med. 30, 179–188 (2011). · DOI · Paper page
  5. McCrory, P. et al. Consensus statement on concussion in sport—the 3rd International Conference on Concussion in Sport held in Zurich, November 2008. Phys. Sportsmed. 37, 141–159 (2009). · DOI
  6. Røe, C., Sveen, U., Alvsåker, K. & Bautz-Holter, E. Post-concussion symptoms after mild traumatic brain injury: influence of demographic factors and injury severity in a 1-year cohort study. Disabil. Rehabil. 31, 1235–1243 (2009). · DOI
  7. Williams, W. H., Potter, S. & Ryland, H. Mild traumatic brain injury and postconcussion syndrome: a neuropsychological perspective. J. Neurol. Neurosurg. Psychiatry 81, 1116–1122 (2010). · DOI
  8. Meaney, D. F. & Smith, D. H. Biomechanics of concussion. Clin. Sports Med. 30, 19–31 (2011). · DOI · Paper page
  9. Smith, D. H. & Meaney, D. F. Axonal damage in traumatic brain injury. The Neuroscientist 6, 483–495 (2000). · DOI · Paper page
  10. Wolf, J. A., Stys, P. K., Lusardi, T., Meaney, D. & Smith, D. H. Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels. J. Neurosci. 21, 1923–1930 (2001). · DOI · Paper page
  11. Saatman, K. E., Creed, J. & Raghupathi, R. Calpain as a therapeutic target in traumatic brain injury. Neurotherapeutics 7, 31–42 (2010). · DOI
  12. Giza, C. C. & Hovda, D. A. The neurometabolic cascade of concussion. J. Athl. Train. 36, 228–235 (2001).
  13. Tang-Schomer, M. D., Patel, A. R., Baas, P. W. & Smith, D. H. Mechanical breaking of microtubules in axons during dynamic stretch injury underlies delayed elasticity, microtubule disassembly, and axon degeneration. FASEB J. 24, 1401–1410 (2010). · DOI · Paper page
  14. Tang-Schomer, M. D., Johnson, V. E., Baas, P. W., Stewart, W. & Smith, D. H. Partial interruption of axonal transport due to microtubule breakage accounts for the formation of periodic varicosities after traumatic axonal injury. Exp. Neurol. 233, 364–372 (2012). · DOI · Paper page
  15. Povlishock, J. T., Becker, D. P., Cheng, C. L. & Vaughan, G. W. Axonal change in minor head injury. J. Neuropathol. Exp. Neurol. 42, 225–242 (1983). · DOI · Paper page
  16. Povlishock, J. T. & Becker, D. P. Fate of reactive axonal swellings induced by head injury. Lab. Invest. 52, 540–552 (1985).
  17. Lipton, M. L. et al. Multifocal white matter ultrastructural abnormalities in mild traumatic brain injury with cognitive disability: a voxel-wise analysis of diffusion tensor imaging. J. Neurotrauma 25, 1335–1342 (2008). · DOI
  18. Niogi, S. N. et al. Extent of microstructural white matter injury in postconcussive syndrome correlates with impaired cognitive reaction time: a 3T diffusion tensor imaging study of mild traumatic brain injury. AJNR Am. J. Neuroradiol. 29, 967–973 (2008). · DOI · Paper page
  19. Iverson, G. L., Gaetz, M., Lovell, M. R. & Collins, M. W. Cumulative effects of concussion in amateur athletes. Brain Inj. 18, 433–443 (2004). · DOI · Paper page
  20. Brooks, W. M. et al. Metabolic and cognitive response to human traumatic brain injury: a quantitative proton magnetic resonance study. J. Neurotrauma 17, 629–640 (2000). · DOI
  21. Anderson, V., Catroppa, C., Morse, S., Haritou, F. & Rosenfeld, J. Recovery of intellectual ability following traumatic brain injury in childhood: impact of injury severity and age at injury. Pediatr. Neurosurg. 32, 282–290 (2000). · DOI
  22. Prins, M. L. & Hovda, D. A. Developing experimental models to address traumatic brain injury in children. J. Neurotrauma 20, 123–137 (2003). · DOI
  23. Duhaime, A. C. Large animal models of traumatic injury to the immature brain. Dev. Neurosci. 28, 380–387 (2006). · DOI
  24. Pinto, P. S., Meoded, A., Poretti, A., Tekes, A. & Huisman, T. A. The unique features of traumatic brain injury in children. Review of the characteristics of the pediatric skull and brain, mechanisms of trauma, patterns of injury, complications, and their imaging findings—part 2. J. Neuroimaging 22, e18–e41 (2012). · DOI
  25. Pinto, P. S., Poretti, A., Meoded, A., Tekes, A. & Huisman, T. A. The unique features of traumatic brain injury in children. Review of the characteristics of the pediatric skull and brain, mechanisms of trauma, patterns of injury, complications and their imaging findings—part 1. J. Neuroimaging 22, e1–e17 (2012). · DOI
  26. Martland, H. Punch drunk. JAMA 91, 1103–1107 (1928). · DOI · Paper page
  27. Roberts, A. H. Brain Damage in Boxers: a Study of the Prevalence of Traumatic Encephalopathy Among Ex-Professional Boxers (Pitman Medical Scientific Publications, London, 1969).
  28. Jordan, B. D. et al. Apolipoprotein E ε4 associated with chronic traumatic brain injury in boxing. JAMA 278, 136–140 (1997). · DOI · Paper page
  29. Stern, R. A. et al. Long-term consequences of repetitive brain trauma: chronic traumatic encephalopathy. PM R 3, S460–S467 (2011). · DOI · Paper page
  30. Mendez, M. F. The neuropsychiatric aspects of boxing. Int. J. Psychiatry Med. 25, 249–262 (1995). · DOI
  31. Tokuda, T., Ikeda, S., Yanagisawa, N., Ihara, Y. & Glenner, G. G. Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid β-protein and tau protein. Acta Neuropathol. 82, 280–285 (1991). · DOI
  32. Jordan, B. D. Clinical spectrum of sports-related traumatic brain injury. Nat. Rev. Neurol. (in press).
  33. Tibbling, G., Link, H. & Ohman, S. Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand. J. Clin. Lab. Invest. 37, 385–390 (1977). · DOI
  34. Csuka, E. et al. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-α, TGF-β1 and blood–brain barrier function. J. Neuroimmunol. 101, 211–221 (1999). · DOI · Paper page
  35. Kossmann, T. et al. Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock 4, 311–317 (1995). · DOI · Paper page
  36. Blennow, K. et al. No neurochemical evidence of brain injury after blast overpressure by repeated explosions or firing heavy weapons. Acta Neurol. Scand. 123, 245–251 (2011). · DOI
  37. Zetterberg, H. et al. Neurochemical aftermath of amateur boxing. Arch. Neurol. 63, 1277–1280 (2006). · DOI · Paper page
  38. Kirchhoff, C. et al. Cerebrospinal IL-10 concentration is elevated in non-survivors as compared to survivors after severe traumatic brain injury. Eur. J. Med. Res. 13, 464–468 (2008).
  39. Goodman, J. C., Van, M., Gopinath, S. P. & Robertson, C. S. Pro-inflammatory and pro-apoptotic elements of the neuroinflammatory response are activated in traumatic brain injury. Acta Neurochir. Suppl. 102, 437–439 (2008). · DOI
  40. Buttram, S. D. et al. Multiplex assessment of cytokine and chemokine levels in cerebrospinal fluid following severe pediatric traumatic brain injury: effects of moderate hypothermia. J. Neurotrauma 24, 1707–1717 (2007). · DOI
  41. Phillips, D. J. et al. Activin A release into cerebrospinal fluid in a subset of patients with severe traumatic brain injury. J. Neurotrauma 23, 1283–1294 (2006). · DOI
  42. Maier, B. et al. Delayed elevation of soluble tumor necrosis factor receptors p75 and p55 in cerebrospinal fluid and plasma after traumatic brain injury. Shock 26, 122–127 (2006). · DOI
  43. Shiozaki, T. et al. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock 23, 406–410 (2005). · DOI
  44. Singhal, A. et al. Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury. J. Neurotrauma 19, 929–937 (2002). · DOI
  45. Stahel, P. F. et al. Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood–brain barrier dysfunction in patients with traumatic brain injury. J. Neurotrauma 18, 773–781 (2001). · DOI
  46. Bell, M. J. et al. Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. J. Neurotrauma 14, 451–457 (1997). · DOI
  47. Trojanowski, J. Q., Schuck, T., Schmidt, M. L. & Lee, V. M. Distribution of tau proteins in the normal human central and peripheral nervous system. J. Histochem. Cytochem. 37, 209–215 (1989). · DOI · Paper page
  48. Friede, R. L. & Samorajski, T. Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice. Anat. Rec. 167, 379–387 (1970). · DOI · Paper page
  49. Franz, G. et al. Amyloid β1–42 and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology 60, 1457–1461 (2003). · DOI · Paper page
  50. Zemlan, F. P. et al. C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res. 947, 131–139 (2002). · DOI
  51. Blennow, K. & Nellgård, B. Amyloid β1–42 and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology 62, 159–160 (2004). · DOI
  52. Ost, M. et al. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology 67, 1600–1604 (2006). · DOI · Paper page
  53. Neselius, S. et al. CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma. PLoS ONE 7, e33606 (2012). · DOI · Paper page
  54. Liu, Q. et al. Neurofilament proteins in neurodegenerative diseases. Cell. Mol. Life Sci. 61, 3057–3075 (2004). · DOI
  55. Siman, R. et al. A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. J. Neurotrauma 26, 1867–1877 (2009). · DOI
  56. Olsson, B., Zetterberg, H., Hampel, H. & Blennow, K. Biomarker-based dissection of neurodegenerative diseases. Prog. Neurobiol. 4, 520–534 (2011). · DOI
  57. Scarna, H. et al. Neuron-specific enolase as a marker of neuronal lesions during various comas in man. Neurochem. Int. 4, 405–411 (1982). · DOI
  58. Bohmer, A. E. et al. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury. Neurosurgery 68, 1624–1631 (2011). · DOI
  59. Chiaretti, A. et al. NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children. Neurology 72, 609–616 (2009). · DOI
  60. Varma, S. et al. F2-isoprostane and neuron-specific enolase in cerebrospinal fluid after severe traumatic brain injury in infants and children. J. Neurotrauma 20, 781–786 (2003). · DOI
  61. Berger, R. P. et al. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 109, E31 (2002). · DOI
  62. Ross, S. A., Cunningham, R. T., Johnston, C. F. & Rowlands, B. J. Neuron-specific enolase as an aid to outcome prediction in head injury. Br. J. Neurosurg. 10, 471–476 (1996). · DOI
  63. Berger, R. P. et al. Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: a possible screening tool. Pediatrics 117, 325–332 (2006). · DOI
  64. Ramont, L. et al. Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin. Chem. Lab. Med. 43, 1215–1217 (2005). · DOI
  65. Moore, B. W. & McGregor, D. Chromatographic and electrophoretic fractionation of soluble proteins of brain and liver. J. Biol. Chem. 240, 1647–1653 (1965). · DOI · Paper page
  66. Isobe, T., Ishioka, N. & Okuyama, T. Structural relation of two S-100 proteins in bovine brain; subunit composition of S.-100A protein. Eur. J. Biochem. 115, 469–474 (1981). · DOI
  67. Nylen, K. et al. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury. Acta Neurochir. (Wien) 150, 221–227 (2008). · DOI
  68. Czeiter, E. et al. Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator. J. Neurotrauma 29, 1770–1778 (2012). · DOI
  69. McKenzie, J. E., Gentleman, S. M., Roberts, G. W., Graham, D. I. & Royston, M. C. Increased numbers of β APP-immunoreactive neurones in the entorhinal cortex after head injury. Neuroreport 6, 161–164 (1994). · DOI
  70. Sherriff, F. E., Bridges, L. R. & Sivaloganathan, S. Early detection of axonal injury after human head trauma using immunocytochemistry for β-amyloid precursor protein. Acta Neuropathol. 87, 55–62 (1994). · DOI · Paper page
  71. Gentleman, S. M. et al. Axonal injury: a universal consequence of fatal closed head injury? Acta Neuropathol. 89, 537–543 (1995). · DOI · Paper page
  72. Ahlgren, S., Li, G. L. & Olsson, Y. Accumulation of β-amyloid precursor protein and ubiquitin in axons after spinal cord trauma in humans: immunohistochemical observations on autopsy material. Acta Neuropathol. 92, 49–55 (1996). · DOI
  73. Gleckman, A. M., Bell, M. D., Evans, R. J. & Smith, T. W. Diffuse axonal injury in infants with nonaccidental craniocerebral trauma: enhanced detection by β-amyloid precursor protein immunohistochemical staining. Arch. Pathol. Lab. Med. 123, 146–151 (1999). · DOI
  74. McKenzie, K. J. et al. Is β-APP a marker of axonal damage in short-surviving head injury? Acta Neuropathol. 92, 608–613 (1996). · DOI
  75. Smith, D. H., Chen, X. H., Iwata, A. & Graham, D. I. Amyloid β accumulation in axons after traumatic brain injury in humans. J. Neurosurg. 98, 1072–1077 (2003). · DOI
  76. Uryu, K. et al. Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans. Exp. Neurol. 208, 185–192 (2007). · DOI · Paper page
  77. Chen, X. H., Johnson, V. E., Uryu, K., Trojanowski, J. Q. & Smith, D. H. A lack of amyloid β plaques despite persistent accumulation of amyloid β in axons of long-term survivors of traumatic brain injury. Brain Pathol. 19, 214–223 (2009). · DOI · Paper page
  78. Roberts, G. W., Gentleman, S. M., Lynch, A. & Graham, D. I. β A4 amyloid protein deposition in brain after head trauma. Lancet 338, 1422–1423 (1991). · DOI · Paper page
  79. Graham, D. I., Gentleman, S. M., Lynch, A. & Roberts, G. W. Distribution of β-amyloid protein in the brain following severe head injury. Neuropathol. Appl. Neurobiol. 21, 27–34 (1995). · DOI
  80. Horsburgh, K. et al. β-amyloid (Aβ)42(43), Aβ42, Aβ40 and apoE immunostaining of plaques in fatal head injury. Neuropathol. Appl. Neurobiol. 26, 124–132 (2000). · DOI
  81. Raby, C. A. et al. Traumatic brain injury increases β-amyloid peptide1–42 in cerebrospinal fluid. J. Neurochem. 71, 2505–2509 (1998). · DOI
  82. Olsson, A. et al. Marked increase of β-amyloid1–42 and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury. J. Neurol. 251, 870–876 (2004). · DOI
  83. Mortberg, E. et al. Plasma tau protein in comatose patients after cardiac arrest treated with therapeutic hypothermia. Acta Anaesthesiol. Scand. 55, 1132–1138 (2011). · DOI
  84. Rissin, D. M. et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat. Biotechnol. 28, 595–599 (2010). · DOI · Paper page
  85. Mondello, S. et al. Blood-based diagnostics of traumatic brain injuries. Expert Rev. Mol. Diagn. 11, 65–78 (2011). · DOI
  86. Kovesdi, E. et al. Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics. Acta Neurochir. (Wien) 152, 1–17 (2010). · DOI
  87. Mussack, T. et al. Significance of Elecsys S100 immunoassay for real-time assessment of traumatic brain damage in multiple trauma patients. Clin. Chem. Lab. Med. 44, 1140–1145 (2006). · DOI
  88. Rothoerl, R. D. & Woertgen, C. High serum S100B levels for trauma patients without head injuries. Neurosurgery 49, 1490–1493 (2001). · DOI
  89. Anderson, R. E., Hansson, L. O., Nilsson, O., Dijlai-Merzoug, R. & Settergren, G. High serum S100B levels for trauma patients without head injuries. Neurosurgery 48, 1255–1260 (2001).
  90. Romner, B. & Ingebrigtsen, T. High serum S100B levels for trauma patients without head injuries. Neurosurgery 49, 1490–1493 (2001). · DOI
  91. Stalnacke, B. M., Ohlsson, A., Tegner, Y. & Sojka, P. Serum concentrations of two biochemical markers of brain tissue damage S-100B and neurone specific enolase are increased in elite female soccer players after a competitive game. Br. J. Sports Med. 40, 313–316 (2006). · DOI
  92. Blyth, B. J. et al. Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood–brain barrier function after traumatic brain injury. J. Neurotrauma 28, 2453–2462 (2011). · DOI
  93. Metting, Z., Wilczak, N., Rodiger, L. A., Schaaf, J. M. & van der Naalt, J. GFAP and S100B in the acute phase of mild traumatic brain injury. Neurology 78, 1428–1433 (2012). · DOI
  94. Berger, R. P. et al. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children. J. Neurosurg. 103, 161–68 (2005).
  95. Zurek, J. & Fedora, M. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir. (Wien) 154, 193–103 (2012). · DOI
  96. Zurek, J., Bartlova, L. & Fedora, M. Hyperphosphorylated neurofilament NF-H as a predictor of mortality after brain injury in children. Brain Inj. 25, 221–226 (2011). · DOI
  97. Tisdall, M. & Petzold, A. Comment on “chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model”. Sci. Transl. Med. 4, 157le158 (2012). · DOI
  98. Riederer, B. M., Zagon, I. S. & Goodman, S. R. Brain spectrin(240/235) and brain spectrin(240/235E): two distinct spectrin subtypes with different locations within mammalian neural cells. J. Cell Biol. 102, 2088–2097 (1986). · DOI
  99. Pike, B. R. et al. Accumulation of non-erythroid α II-spectrin and calpain-cleaved α II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. J. Neurochem. 78, 1297–1306 (2001). · DOI
  100. Pineda, J. A. et al. Clinical significance of αII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J. Neurotrauma 24, 354–366 (2007). · DOI
  101. Farkas, O. et al. Spectrin breakdown products in the cerebrospinal fluid in severe head injury—preliminary observations. Acta Neurochir. (Wien) 147, 855–861 (2005). · DOI
  102. Mondello, S. et al. αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients. J. Neurotrauma 27, 1203–1213 (2010). · DOI
  103. Wilkinson, K. D. et al. The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science 246, 670–673 (1989). · DOI · Paper page
  104. Papa, L. et al. Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention. J. Trauma Acute Care Surg. 72, 1335–1344 (2012). · DOI · Paper page
  105. Ottens, A. K. et al. Neuroproteomics in neurotrauma. Mass Spectrom. Rev. 25, 380–408 (2006). · DOI
  106. Pasinetti, G. M., Ho, L., Dooley, C., Abbi, B. & Lange, G. Select non-coding RNA in blood components provide novel clinically accessible biological surrogates for improved identification of traumatic brain injury in OEF/OIF veterans. Am. J. Neurodegener. Dis. 1, 88–98 (2012).
  107. Pollock, N. J., Mirra, S. S., Binder, L. I., Hansen, L. A. & Wood, J. G. Filamentous aggregates in Pick's disease, progressive supranuclear palsy, and Alzheimer's disease share antigenic determinants with microtubule-associated protein, tau. Lancet 2, 1211 (1986). · DOI
  108. Hall, S. et al. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders. Arch. Neurol., 27, 1–8 (2012).
  109. Dickson, D. W., Kouri, N., Murray, M. E. & Josephs, K. A. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J. Mol. Neurosci. 45, 384–389 (2011). · DOI · Paper page
  110. King, A. et al. Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease. Neuropathology 30, 408–419 (2010). · DOI
  111. Geser, F. et al. On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia. Prog. Neurobiol. 95, 649–662 (2011). · DOI
  112. Guerrero, A. F. & Alfonso, A. Traumatic brain injury-related hypopituitarism: a review and recommendations for screening combat veterans. Mil. Med. 175, 574–580 (2010). · DOI
  113. Tanriverdi, F. et al. Kickboxing sport as a new cause of traumatic brain injury-mediated hypopituitarism. Clin. Endocrinol. (Oxf.) 66, 360–366 (2007). · DOI · Paper page

Cited by

See all 596

Metadata

Authors
Zetterberg, H., Smith, D. H., & Blennow, K.
Venue
Nature Reviews Neurology
Publisher
Springer Science and Business Media LLC
Published
2013-02-12
Volume
9
Issue
4
Pages
201-210
ISSN
  • 1759-4758 (ISSN-L)
  • 1759-4766
DOI
10.1038/nrneurol.2013.9
OpenAlex
W2062993238
Cited by
596
References
25
FWCI
6.83
Type
journal article
Language
en
Open access
green
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.